SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-010284
Filing Date
2020-05-11
Accepted
2020-05-11 16:05:15
Documents
3
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20200510_8k.htm 8-K 22398
2 EXHIBIT 99.1 ex_186013.htm EX-99.1 117194
3 logo.jpg GRAPHIC 18839
  Complete submission text file 0001437749-20-010284.txt   166743
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 20864724
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences